S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CGEM Cullinan Therapeutics Inc

22.84

0.00 (0.00%)

Pre Market

Last Updated: 06:00:11

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 4 June 2024 (1 day ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 4 June 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 3 June 2024 (3 days ago) • Edgar (US Regulatory)

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
Saturday 1 June 2024 (5 days ago) • GlobeNewswire Inc.

Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
Friday 24 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 23 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024
Thursday 23 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Wednesday 15 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

More Cullinan Therapeutics Inc News Articles

Clean Vision (QB)

Himalaya Technologies (PK)

Astra Veda (PK)

MicroCloud Hologram

Asia Broadband (PK)

Global Developments (PK)

Brookmount Explorations (PK)

Decentral Life (PK)

NioCorp Developments

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions